Skip to main content

Table 4 Tumor and liver dose correlations with anatomic/functional findings and administered activity

From: Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio

 

Tumor dose (Gy)

Liver dose (Gy)

Tumor involvement (%)

p = 0.003*

p < 0.0001*

Tumor to liver ratio

p < 0.0001*

p = 0.47

Administered activity

p > 0.99

p < 0.0001*

Disease type

p = 0.65

p = 0.20